Motion Stimulation Therapy Market Forecast 2022 to 2032 | By Boston Scientific, Medtronic, Cyberonics, Bioness

When muscle denervation, paralysis, or weakness occur as a result of an incident such as a stroke or spinal cord damage, motion stimulation therapy is used. It helps to generate the voluntary forces required for joint movements, allowing for more functional completion of daily tasks.

The Motion Stimulation Therapy Market Size was estimated to be approximately US$ 1.2 million in FY 2022. The market is estimated to grow at a CAGR of 4.1% between 2022 and 2032, reaching US$ 1.8 million.

Request Sample Copy of Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-8419

Motion stimulation therapy can help with muscle spasms, discomfort, and inflammation, as well as preventing muscle atrophy. It may also be beneficial in the treatment of Parkinson’s disease, a progressive neurological ailment that primarily affects the elderly.

Deep brain stimulation is the most common surgical treatment for Parkinson’s disease. It is a motion stimulation therapy. Advanced motion stimulation techniques, such as functional and therapeutic electric stimulation, are also commonly employed to improve results and speed up recovery from muscular dysfunction. These therapies make use of electrical impulses to contract and activate muscles.

Which are Some Prominent Drivers Spearheading Motion stimulation therapy Market Growth?

The increasing prevalence of Parkinson’s disease, as well as the rising incidence of traffic accidents and muscular injuries, are driving the expansion of the motion stimulation market. Motion stimulation therapy is frequently utilised in conjunction with regular medication, which will push market expansion even further. Furthermore, developments in stimulator device technology are fueling market expansion.

During the projected period, the worldwide Motion Stimulation Therapy market is expected to rise significantly, with government support for novel drug research playing a major role. According to the Parkinson’s Association of the Carolinas, around 60,000 people are diagnosed with Parkinson’s disease in the United States each year, with an estimated 10 million people globally living with the disease.

Contact us for discount@ https://www.futuremarketinsights.com/request-discount/rep-gb-8419

The functional neuromuscular stimulation therapy segment is predicted to hold the largest market share in the motion stimulation therapy market due to the increasing prevalence of Parkinson’s disease internationally. The increased number of patients seeking motion stimulation therapy is expected to cause hospitals to be the most prominent end-user category.

How is North America Contributing to the Growth of the Motion stimulation therapy Market?

Because of rising musculoskeletal problems and increased fitness consciousness, the motion stimulation therapy market in North America is predicted to develop at a CAGR of 4.8 percent during the forecast period. The World Health Organisation (WHO), for example, announced in February 2021 that over 1.71 billion individuals worldwide suffer from musculoskeletal problems.

The North American area is well-positioned to reign supreme in the worldwide muscle stimulation devices market due to high expenditure on healthcare items, favourable reimbursement regulations, and rising acceptance among inactive consumers.

Key Companies Profiled:
Valencia CA USA, , Cyberonics, , Medtronic, , Innovative Neurotronics Inc., , Boston Scientific Corporation, , Bioness Inc., , St. Jude Medical Inc., , Nevro Corporation

Get Report Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-8419

Key Segments Covered in the Motion Stimulation Therapy Market Study

Motion Stimulation Therapy Market by Therapy Type:

• Functional Neuromuscular Motion Stimulation Therapy
• Peripheral Motion Stimulation Therapy
• Deep Brain Motion Stimulation Therapy
• Therapeutic Electrical Motion Stimulation Therapy

Motion Stimulation Therapy Market by End User:

• Motion Stimulation Therapy across Hospitals
• Motion Stimulation Therapy across Specialty Clinics
• Motion Stimulation Therapy across Other End User

About Future Market Insights, Inc.

Future Market Insights, Inc. (ESOMAR certified, Stevie Award – recipient market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs